The study by Wang Zhujuan et al found that MALAT1 was overexpressed in sunitinib-resistant renal cell carcinoma tissues and cells, indicating that knockout of MALAT1 inhibited chemotherapy resistance, cell proliferation and invasiveness, and enhanced apoptosis. This evidence concerns the gene MALAT1 and renal cell carcinoma.